A
1. Treatment Seeking Among Persons with Hypomania (BP II)
V. Agosti
2. Bipolar Depression: Differential Clinical Picture from Unipolar
Depression
J.F. Allilaire, E.G. Hantouche, H.S. Akiskal, S. Lancrenon, J.M. Azorin,
M.D., M. Bourgeois, M.D., D. Sechter, L. Chatenêt-Duchêne
3. Interpersonal Problems of Bipolar Patients and the Course of the Illness
A.C.F. Andrade, F. Lotufo Neto; C. M. L. Moraes, L. Russo
4. Safety and Tolerability of Lamotrigine in Controlled Mood Disorder
Trials
J. Ascher, N. Earl, S. Brook, R. Emsley, S. Frangou, L. Davis, D. Feifel,
J. McEvoy
5. Case Report of 5 Bipolar Disorder Patients (Rapid Cycling) Followed
for 3 Years, Treated with Lamotrigine
S. A. Asghar
6. Childhood-onset Bipolar Disorder: IQ Testing
N.B. Austin, D.F. Papolos, G.L. Faedda
B
7. Depression During Mania: Treatment Response to Olanzapine or Placebo?
R.W. Baker, M.D., M. Tohen, M.D., Dr. PH, R.C. Risser, M.S., V.L. Stauffer,
Pharm.D., A. Breier, M.D., and G.D. Tollefson, M.D., Ph.D.
8. Olanzapine is Not Associated with Exacerbation of Bipolar Mania
R.W. Baker, M.D., D.R. Milton, M.S., M.F. Tohen, M.D., Dr. PH., V.L.
Stauffer,. Pharm.D., A. Breier M.D.
9. Double-Blind Comparison of Lamotrigine vs. Valproate on Mood & Body
Weight
P.S. Barrett, A. Vuong, V. Biton, K. Edwards, W. Mirza, D.
Kalogjera-Sackellares, J.C. Sackellares, G. Montouris
10. Effects of Supraphysiological Levothyroxine (T4) on Cerebral Glucose
Metabolism in Bipolar Depression: Findings from a Positron Emission Tomographic
Study
M. Bauer, E.D. London, N. Rasgon, S. Berman, M. Mandelkern, M. Frye, J.J.
Mazziotta, L. Altshuler, A.K. Shinn, M. Gitlin, P. C. Whybrow
11. A New Clinical and Research Tool for Bipolar Disorder: ChronoRecord
Software for Daily Self-Reporting of Mood, Sleep and Medications
M. Bauer, L. Gyulai, T. Glenn, P. C. Whybrow
12. Risperidone as an Adjunctive Treatment in Mixed Mania
A. Benabarre, E. Vieta, A. Martínez-Aràn, J.M. Goikolea, B. Corbella, G.
Martínez, A. Fernàndez
13. Increasing Reliability of Bipolar II Diagnosis
F. Benazzi
14. PTSD Onset Age: A Predictor of Psychiatric Comorbidity and Response to
Topiramate
J. Berlant, M.D., Ph.D.
15. Morphometric Evidence of Hyperactivated Dorsal Raphe Neurons in
Primary Mood Disorders
H. Bielau, P. Danos, D. Krell, S. Diekmann, H.G. Bernstein, B. Baumann, B.
Bogerts
16. Bipolar Disorder and Borderline Personality Disorder Comorbidity: A
Review of Epidemiological Data
L. Biéler, F. Ferrero, G. Bertschy
17. Lamotrigine Demonstrates Long-Term Mood Stabilization in Manic
Patients
C.L. Bowden, J.R. Calabrese, S. Akthar, M. Olajossy, S. Montgomery, P.
Montgomery, J. Ascher, N. Earl
18. Are Amygdala Volumes Increased in Bipolar Disorder Patients?
P. Brambilla, K. Harenski, M. Nicoletti, R.B. Sassi, A.G. Mallinger, E.
Frank, D.J. Kupfer, M.S. Keshavan, J.C.Soares
19. Glutamatergic Abnormalities in the Left Dorso-lateral Prefrontal
Cortex in Unmedicated Unipolar Disorder Patients: A Preliminary Study
P. Brambilla, J.A. Stanley, K. Harenski, M. Nicoletti, A.G. Mallinger, E.
Frank, D.J. Kupfer, M.S. Keshavan and J.C.Soares
20. Reliability of Telephone Interviews in Assessing Bipolar Disorder I
L.K. Brar, J.S. Brar, N.G. Deily, J.A. Wood, P.M. Reitz, D.J. Kupfer, V.L.
Nimgaonkar
21. Quetiapine in Patients with Bipolar Disorder and Cocaine Dependence
E.S. Brown, V.A. Nejtek, D.C. Perantie, L. Bobadilla
C
22. Lamotrigine: Evidence for Mood Stabilization in Bipolar I Depression
J.R Calabrese, C.L. Bowden, S. Akthar, M. Olajossy, S. Montgomery, P.
Montgomery, J. Ascher, N. Earl
23. Leukocytosis and Hypoalbuminemia in Mixed Bipolar States: Evidence for
Immune Activation
F. Cassidy, W.H. Wilson, B.J. Carroll
24. Vascular Risk Factors in Late Onset Mania
F. Cassidy, B.J. Carroll
25. Orbital Frontal Metabolite Changes in Bipolar Disorder: A Proton
Magnetic Resonance Spectroscopy Study
K.M. Cecil, W.S. Ball, M.P. DelBello, S.M. Strakowski
26. Non-Manic Depressive Bipolar Disorders. The Need of Validating Cycloid
Psychoses
M.G. Cetkovich-Bakmas; G.V. Vázquez
27. Alterated cAMP-dependent Protein Kinase Subunit Immunolabeling in
Postmortem Brain from Patients with Bipolar Affective Disorder
A. Chang, P. P. Li, S. Kish, J. J. Warsh
28. Clinical Response to Quetiapine Add-on for Treatment Refractory
Bipolar Disorder
K. Chisholm, T. Suppes
29. Psychoeducation and Prevention of Relapse in Bipolar Disorders:
Preliminary Results
F.Colom, A. Martínez-Arán, M.Reinares, A.Benabarre, B.Corbella, E.Vieta
30. Early Sexual Abuse and Clinical Features in Bipolar Disorder
R.G. Cooke, D.K. Whitney, E. Munco, S.V. Parikh, C. Miller, L. Lee, J.L.
Kennedy
D
31. Carbamazepine but Not Lithium Salts Prevents the Development of
Behavioural Supersensitivity to Dopamine Agonists Induced by Chronic Imipramine
P.S. D'Aquila, A.T. Peana, O. Tanda, M. Collu, P. Devoto, G.Serra
32. Episodic Memory Dysfunction in Bipolar Disorder
T.D. Deckersbach, N. Reilly-Harrington, G. Sachs
33. Quetiapine as Adjunctive Treatment for Adolescent Mania
M.P. DelBello, H.L. Rosenberg, A.M. Hudepohl, S.M. Strakowski
34. A Case Control Study in the Use of Telemedicine for Treatment
Adherence in Remote and Rural Bipolar Patients
R. D’Souza, H. Hustig
35. An Open Label Study of Resperidone and Serteraline in the Treatment Of
Rural Patients with Bipolar 1 Depression
R. D’Souza, C. Kingston, M. Scurrah, J. Williams
36. The Maudsley Bipolar Disorder Project: The Effect of Age of Onset on
the Neuropsychological Profile of Biplolar I Disorder
S. Donaldson, L.H. Goldstein, V. Raymont, S. Frangou
37. Prospective Longitudinal Follow-Up Study of the Offspring of Lithium
Responsive and Lithium Non-Responsive Bipolar Parents
A. Duffy, M. Alda, S. Kutcher, C. Robertson, P. Cavazzoni, E. Grof, and P.
Grof
E
38. New Information Confirming the Importance of Dosing and Rash with
Lamotrigine
N.L. Earl, J. Ascher and J. Messenheimer
39. Antidepressant Exposure in Children Diagnosed with Bipolar Disorder
R.S. El-Mallakh, M.D.,* D. Cicero, J. Holman, M.D., J. Robertson, M.D.
40. Intracerebroventricular Ouabain Models Mania in Rats
R.S. El-Mallakh, M.O. Huff, X.P. Li, S. Decker, R.S. Levy
F
41. Baseline Body Mass Index as a Correlate of Outcome in Patients with
Bipolar I Disorder
A. Fagiolini, E. Frank, P.R. Houck, and D.J. Kupfer
42. Combination Lithium Carbonate and Divalproex Sodium Treatment of
Pediatric Bipolar Disorder
R.L. Findling, B.L. Gracious, N.K. McNamara, J.R. Calabrese
43. The Prevention of Bipolar Disorder in Genetically At-Risk Youths
R.L. Findling, B.L. Gracious, N.K. McNamara, J.R. Calabrese
44. Influence of Age and Executive Functioning on Verbal Memory of
Patients with Unipolar and Bipolar Depression
P. Fossati, A.M. Ergis, J.F. Allilaire
45. Lifetime Influence of Panic Spectrum Symptoms on Treatment Outcome of
Bipolar I Disorder
E. Frank, J. Cyranowski, P. Rucci, A.G. Mallinger, H. Swartz, M.E. Thase,
D.J. Kupfer
46. Health Care Utilization in Bipolar Disorder & Comorbid Substance Abuse
M.A. Frye, L.L. Altshuler, A. Sanders, A. Cozzolino, S. Masseling, J. Mintz
G
47. Bipolar Disorder: Assessing Treatment Response in a Naturalistic
Setting
J. Garnham, A. Munro, A. Teehan, A. Duffy, M. MacDougall, M. Passmore, C.
Slaney, M. Alda
48. A Case Management Protocol for Patients with Bipolar Disorder
E. L. George, D.O. Taylor, D.J. Miklowitz
49. Seroquel Treatment of Rapid-Cycling Bipolar Disorder: An Open
Prospective Study
S.N. Ghaemi, J.F. Goldberg, J.Y. Ko, L. Oakley
50. Topiramate Treatment of Bipolar Spectrum Disorders: A Retrospective
Chart Review
S.N. Ghaemi, S.G. Manwani, J.J. Katzow, J.Y. Ko, F.K. Goodwin
51. Prevalence and Risks Associated with Antidepressant-Induced Mania
J. F. Goldberg, A. Rabin, J. Whiteside
52. Elevated TSH in Bipolar Youth Prescribed Both Lithium and Divalproex
Sodium
B.L.Gracious; R.L.Findling; N.K.McNamara; E.A.Youngstrom; J.R.Calabrese
53. A Parent Version of the Young Mania Rating Scale
B.L. Gracious, R.L. Findling; E. A. Youngstrom; C.A. Demeter; J.R. Calabrese
54. Adapting Psychotherapy for Treating Bipolar Children and Adolescents
R. Graef, M. Enos
55. Lamotrigine in Rapid Cycling Bipolar Disorder: Predictors of Response
P. Greene, T. Suppes, C.L. Bowden, J.R. Calabrese, L. Gyulai, G. Sachs, J.
Ascher, T. Smoot, N. Earl
56. Association of Newly Reported Diabetes and Antipsychotics in Mood
Disorder Patients: Findings from a Large Health Plan Database
A. Grogg, F. Gianfrancesco, J. Meyers, R. Wang
57. Risperidone Plus Mood Stabilizer versus Placebo Plus Mood Stabilizer in
Patients with Bipolar Disorder: A Combined Efficacy Analysis
F. Grossman, A. Okamoto, C. Bowden
58. Comparison of Risperidone and Olanzapine in Bipolar and
Schizoaffective Disorder
S. Gupta, S.Virk, P.S. Masand, X. Wong, T.L. Schwartz, M. Wade
59. Traumatized Children, Bipolar Disorder and Mood Stabilizing Treatment:
A Case Series
R. Guscott, L. Taylor, J. R. Guscott
H
60. Rapid Eye Movement Latency Changes in Manic Patients
M.M. Hanna, R.A. Moreno, S. Tavares
61. Bipolar OCD: Confirmatory Results in Two Populations of OCD
Association Members versus Non-members
E.G. Hantouche, F.J. Kochman, I. Barrot, C. Demonfaucon, H.S. Akiskal
62. Factor Structure of Depression : Comparative Self-assessment in
Bipolar versus Unipolar Depression
E.G. Hantouche, H.S. Akiskal, J.F. Allilaire, S. Lancrenon, J.M. Azorin, M.
Bourgeois, D. Sechter, L. Chatenêt-Duchêne
63. The Influence of Psychosocial Stressors and Psychotherapy on Treatment
Response in Bipolar I Disorder
S.A. Hlastala, E. Frank, P. Rucci, B. Anderson, D.J. Kupfer
64. Ethyl-eicosapentaenoate (LAX-101) in Treatment-unresponsive Depression
D. F. Horrobin, M. Peet
65. Tetraspanin Protein CD151: A Common Target of Mood Stabilizing Drugs?
L.V. Hua, M. Green, A. Wong, J. J. Warsh, P. P. Li
66. Acute Antimanic Efficacy and Safety of Oxcarbazepine in an Open Trial
with an On-Off- On Design
A. Hummel, M.D., R. Stampfer, M.D., H. Grunze, M.D., S. Schlösser, M.A., B.
Amann, M.D., M. Frye, M.D., J. Walden, M.D.
67. Evaluation and Intervention of Prodromal Symptoms of Bipolar Disorder
M.Z. Hussain, M.D., Z.A. Chaudhry, M.D.; S. Hussain, M.D.
68. Topiramate in Treatment of Refractory Bipolar Depression
M.Z. Hussain, M.D., Z.A. Chaudhry, M.D., S. Hussain, M.D.
J
69. Circadian Rhythms, Multilevel Models of Emotion and Bipolar Disorder –
An Initial Step Towards Integration?
S.H. Jones
70. Trends in the Prescribing of Antimanic Agents for Bipolar Disorder
Patients in Korea across a 10-year Span
H.Y. Jung, M.D., Ph.D., S.I. Lee, M.D., Ph.D., Y.R. Kim, M.D., Y.H. Jun,
M.D.
K
71. Olanzapine Yields Rapid Improvement in Diverse Syndromal and
Subsyndromal Exacerbations of Bipolar Disorders
T.A. Ketter, S. Janenawasin, P.W. Wang, M. Schumacher, B. Das, C.M. Santosa,
J. Mongkolcheep, C.M. Strong
72. High Rate of Autoimmune Thyroiditis in Bipolar Disorder is Not
Associated with Lithium
R.W. Kupka, W.A. Nolen, H.A. Drexhage, S.L. McElroy, L.L. Altshuler, K.D.
Denicoff, M.A. Frye, P.E. Keck, G.S. Leverich, A.J. Rush, T. Suppes, C. Pollio,
R.M. Post
73. Neuroimaging of Mathematical Processing in Mood Disorders
V. Kusumakar, F.P. MacMaster, L. Gates, M. Schmidt, S.C. Khan
L
74. Renal Failure in Long-Term Lithium Treatment
E. Lepkifker, A. Sverdlik, I. Iancu, R. Ziv
75. Possible Role Of 3’(2’)-Phosphoadenosine 5’-Phosphate Phosphatase and
Bipolar Disorder
J. Levine, G. Shaltiel, R.H. Belmaker and G. Agam
76. A Measure for Assessing Provider Support of Patient Self-Management of
Bipolar Disorder
E.J. Ludman, G.E. Simon, C.M. Rutter, M.S. Bauer, J. Unutzer
M
77. Maritime Bipolar Registry
M. MacDougall, C. Slaney, V. Kusumakar, M. Alda
78. ABSTRACT WITHDRAWN
79. Clinical Experience with Vagus Nerve Stimulation (VNS) for the
Treatment of Resistant Depression in Bipolar Disorder
L.B.Marangell, A.J. Rush, M S. George, M M. Husain, Z Nahas, S.H. Lisanby,
C.R. Johnson, H.A. Sackeim
80. Longer-term Treatment with Topiramate for Bipolar Disorder
D.B. Marcotte, M.D., E. Gullick, Ph.D.
81. Divalproex and Females with Bipolar Disorder: Reproductive and
Metabolic Risk Profile
R.S. McIntyre, D.A., Mancini, S.M. McCann, J. Srinivasan, S.H. Kennedy
82. Randomised, Single-blind Comparison of Topiramate and Bupropion SR as
Add-on Therapy in Bipolar Depression
R.S. McIntyre, D.A. Mancini, S.M. McCann, J. Srinivasan, D. Sagman, S.H.
Kennedy
83. Is There Evidence for a Dysfunction of the Behavior Activation System
in Persons Putatively at Risk for Bipolar Disorder – An EEG Pilot Study
T.D. Meyer, J. Dumlija, M. Blenk, E. Wascher
84. Bipolar Disorders, Creativity and Suicidality: A Systematic Study
V. M. Mishra, P.C. Okemos
85. A Multivariate Statistical Analysis of Bipolar Depression and Major
Depressive Disorder
P.B. Mitchell, D. Hadzi-Pavlovic, G. Evoniuk, J.R. Calabrese, C.L. Bowden,
N.L. Earl
86. Third Ventricle Abnormalities in Bipolar Affective Disorder
P.B. Moore, R. Bhadoria, P. Danson, V.L. McAllister, I.N. Ferrier
87. Seasonal Variation in Admissions to Hospital for Mania and Depression
and Correlations with Suicides
G. Morken, S. Lilleeng, O. M. Linaker
88. Risperidone versus Olanzapine for the Treatment of Mood Symptoms in
Patients with Schizophrenia and Schizoaffective Disorder
J. Myers, R. Mahmoud, S. Berry, R. Conley
N
89. Affective Disorders – A Defect of Long-term Synaptic Plasticity? A
Patch-clamp Study and a Novel Pathophysiological Hypothesis
A. Normann, K. Chakalova, J. Bischofberger
O
90. Antechinus Agilis as an Animal Model of Mania
J. P. Othmer, S. Ward, S. Gershon
P
91. Lithium and Valproate Treatment of Pathological Gambling: A Single
Blind Study
S.Pallanti, L. Quercioli, E. Hollander
92. Bipolar Education Treatment Trial: Preliminary Results
S.V. Parikh, A. Kusznir, R. Cooke, C. Parker, E. Pryer, R. McIntyre, R.
Chopra
93. The Bipolar Treatment Optimization Program: A Novel Simultaneous Patient
and Provider Intervention
S.V. Parikh, P.N. Goering, S.H. Kennedy, A. Kusznir, C. Parker, R. Chopra,
L. Norton
94. Bilateral Bargaining Models and Treatment Adherence in Bipolar Disorder
P. B. Peele, C. K. Stockman, J. Kagel, E. Frank
95. The Financial Burden of Bipolar Disorder in Employer-sponsored
Insurance
P. B. Peele, Y. Xu
96. Bipolar Disorder in Women: Affective Symptoms Across the Menstrual
Cycle
D.J. Printz, L. Stricks, A. Das, D. Malaspina, M. Morrell, J.M. Gorman
R
97. Genetic Association Studies in Bipolar Disorder Using Family-based and
Unrelated Controls
R. Ranade, L.K. Brar, K.V. Chowdari, J. Wood, H. Mansour, B. Devlin, D.J.
Kupfer, V.L. Nimgaonkar
98. Menstrual Cycle-related Mood Changes in Women with Bipolar Disorder
N. Rasgon, M. Bauer, L. Gyulai, T. Glenn, P. C. Whybrow
99. The Maudsley Bipolar Disorder Project: Clinical Characteristics of
Bipolar I Disorder in an Epidemiologically Derived Treatment Sample
V. Raymont, S. Frangou
100. The Maudsley Bipolar Disorder Project: Patient Characteristics and
Drug Treatment Choice in Bipolar I Disorder
V. Raymont, S. Frangou
101. Clinical Implications of Psychiatric Comorbidity in Bipolar I Patients
M. Reinares, F. Colom, A. Martínez-Arán, A. Benabarre, J.M. Goikolea, E.
Vieta
S
102. Risperidone plus Mood Stabilizer versus Placebo plus Mood Stabilizer
for Acute Mania of Bipolar Disorder: A Double-blind Comparison of Efficacy and
Safety
G.S. Sachs, S.N. Ghaemi, F. Grossman, C. L. Bowden
103. Differential Pattern of Alcohol Use Profile among Bipolar Alcoholics
I.M. Salloum, J.R. Cornelius, D.C. Daley, L. Kirisci, C.R. Spotts
104. MR Volumetric Analysis Of Pituitary Gland In Bipolar And Unipolar
Disorder Patients
R.B.Sassi , M.Nicoletti, P.Brambilla, K.Harenski, A.G.Mallinger, E.Frank,
D.J.Kupfer, M.S.Keshavan, J.C.Soares
105. White Matter Hyperintensities in Bipolar and Unipolar Mood Disorder
Subjects
R.B.Sassi , P.Brambilla,, M.Nicoletti, A.G.Mallinger, E.Frank , D.J.Kupfer,
M.S.Keshavan, J.C.Soares
106. Differential Efficacy of Moodstabilizers Preventing Antidepressant
Induced Mania
L.O. Schärer, C. Stahlschmidt, J. Peters, C. Biederman S. Walser, X. Hermle,
C. Norman, J. Langosch, J. Walden
107. Evaluation of Long-term Monitoring Methods for Bipolar Disorder
L.O. Schärer, M. Hörn, J. Peters, C. Biederman, S. Walser, C. Norman, J.
Langosch, J. Walden
108. The Use of Tiagabine in the Treatment of Patients with Refractory
Bipolar Disorder
L.C. Schaffer, C.B. Schaffer, J. Howe
109. A Comparison of Bipolar Depression and Recurrent Unipolar Depression in
Bipolar Families
L.G. Schaffner, D.F. MacKinnon
110. Orienting Response and Task Performance in Bipolar Disorder and
Schizophrenia
D.B. Schnur, S. Smith, S.M. Ahmed, S.R. Peteru, M. Nisimova
111. A Pilot Study of Cognitive Therapy in Bipolar Disorders
J. Scott, M.D.
112. Prevalence, Morbid Risk and Small Area Distribution of Bipolar Disorder
in Comparison to Schizophrenia within an Epidemiologically Complete Rural Irish
Catchment Area Population
P.J .Scully, J.M .Owens, A. Kinsella, J.L. Waddington
113. Psychopathology, Cognitive Function and Laterality in Bipolar Disorder
within an Epidemiologically Complete Rural Irish Catchment Area Population
P.J. Scully, J.M. Owens, A. Kinsella, J.L. Waddington
114. Treatment of Mood Disorders in Patients with Family History of Bipolar
Disorder
M. Shetty, P. Mullick, P. Shetty, D. Lynn
115. Clinical and Health Related Quality of Life Outcomes Associated with
Olanzapine in Patients with Bipolar Disorder as Compared with Haloperidol
L. Shi, M. Namjoshi, F. Zhang, E. Edgell, M. Tohen, A. Breier
116. Olanzapine versus Haloperidol: A Prospective Comparison of Clinical and
Work Status Outcomes in Bipolar Disorder
L. Shi, M. Namjoshi, F. Zhang, E. Edgell, M. Tohen, A. Breier
117. A Survey of Stress and Support for Parents of Children with Early-Onset
Bipolar Disorder
D.P. Sisson, M.A. Fristad
118. Suicidality in Bipolar Alcoholics
C.R. Spotts, I.M. Salloum, D.C. Daley, L. Kirisci
119. Assessment of Insight in Mood Disorders: Development of a Rating Scale
B.A. Sproule, E.D. Sturman
T
120. A Prospective Controlled Study of Antidepressant-induced Mania
R.S. Tamada, C.K. Issler, J.A.M.S. Amaral, B. Lafer
121. Pharmacotherapy Treatment Adherence in Patients with Bipolar I Disorder:
Can Motivational Interviewing Strategies Make a Difference?
R.I. Taylor, A.G. Mallinger, M.E. Thase, A. Zuckoff, H. A. Swartz, E. Frank
122. Electro Biochemical Coupling, Excitability of Neurons and Bipolar
Disorder
A.Thiruvengadam
123. A Component Process Analysis of Working Memory Dysfunction in
Prospectively Verified Euthymic Bipolar Patients
J.M. Thompson, J.M. Gray, I.N. Ferrier, J.H. Hughes, S. Watson, A.H. Young
124. Functional MRI Of Verbal Working Memory In Prospectively Verified
Euthymic Bipolar Patients
J.M. Thompson, P.J. Monks, A.J. Lloyd, C.L. Harrison, E.T. Bullmore, M.J.
Brammer, S.C.R. Williams, A. Simmons, R.M. Murray, I.N. Ferrier, V.A. Curtis,
A.H. Young
125. Olanzapine versus Divalproex Sodium for the Treatment of Acute Mania
M. Tohen, M.D, R.W. Baker, M.D., D.R. Milton, M.S., R.C. Risser, M.S. , J.A.
Gilmore, Ph.D., A.R. Davis, R.Ph., A.L. Richey, R.Ph.
126. Olanzapine versus Haloperidol in the Treatment of Acute Mania
M. Tohen, F. Zhang, P.D. Feldman, A.R. Evans, A. Breier
V
127. Increased Frequency of Epileptic Signs in Brief Depressive Periods
with Rapid Changing Symptoms Compared to Major Depression
A.E. Vaaler, G. Morken, O.M. Linaker, T. Sand
128. Gamma Butyrolactone Intoxication and Withdrawal Masquerading as Bipolar
Type I Illness
S. Vogel-Scibilia, M.D
W
129. Determinants of Psychopathology in Children of Bipolar Parents
M. Wals, J. van Os, M.H.J. Hillegers, C.G. Reichart, F.C. Verhulst, W.A.
Nolen, J. Ormel
130. The Short- and Long- Term Impact of Insomnia on Depression and Mania
C.A.Winett, S.L. Johnson, T.A. Mellman
131. Adolescent Depression: Under-recognition and Measures to Promote
Recognition in Scottish Schools
R.M. Wrate, S. Moor, R. Elton, A. Maguire, H. McQueen, G. Bagnall, C. Blair
Y
132. Presynaptic Dopamine Function in First Episode Neuroleptic and Mood
Stabilizer Naïve Non-psychotic Mania and Effects of Treatment with Divalproex
Sodium: A PET Study
L.N. Yatham, P.F. Liddle, I. Shia, R.W. Lam, E. Ngan
133. Risperidone and Mood Stabilizer Combination in Acute and Continuation
Treatment of Mania
L.N. Yatham and the RIS-CAN-25 study group
134. mRNA Levels of the Putative Store-operated Calcium Channel, TRPC7, Are
Reduced in B Lymphoblasts Showing Altered Calcium Homeostasis from Bipolar-I
Disorder Patients
I-S. Yoon, P.P. Li, K-P. Siu, J.L. Kennedy, F. Macciardi, R.G. Cooke, S.V.
Parikh, J.J. Warsh
Z
135. A Randomized Controlled Trial of Adjunctive CBT in the Maintenance
Treatment of Bipolar Disorder
A. E. Zaretsky, S. Parikh, W.E. Lancee
